Bajaj Health Q2 income fell 32% as loss widened to Rs 58 crore

Bajaj Finserv Health Ltd. reported Q2 FY2027 total income of Rs 192 crore, down 32% from Rs 285 crore a year earlier, while its loss after tax widened to Rs 58 crore from Rs 32 crore. The quarter also brought industry structural changes cited by management and continued expansion across TPA, outpatient and government-scheme services.

Why did Bajaj Health's income fall and loss widen in Q2 FY2027?

Bajaj Health reported lower income and a wider loss in Q2 FY2027, although the presentation does not quantify the financial effect of the regulatory developments it identified. Total income declined by Rs 93 crore to Rs 192 crore from Rs 285 crore in Q2 FY2026. Loss after tax increased by Rs 26 crore to Rs 58 crore, compared with a Rs 32 crore loss a year earlier.

The company cited a Reserve Bank of India circular and an Insurance Regulatory and Development Authority of India discussion paper as leading to structural changes in the industry during Q2 FY2027. It did not disclose whether either development affected a specific business vertical, customer relationship or revenue line. Accordingly, the presentation does not establish a direct causal link between those developments and the Rs 93 crore decline in quarterly income.

The first-half comparison shows a similar direction. H1 FY2027 total income was Rs 420 crore against Rs 528 crore in H1 FY2026, while loss after tax increased to Rs 102 crore from Rs 75 crore. For full-year FY2026, Bajaj Health reported income of Rs 1,121 crore and a loss after tax of Rs 160 crore.

How did Bajaj Health's transaction activity change in Q2 FY2027?

Bajaj Health processed 5.694 million healthcare transactions in Q2 FY2027, down from 5.922 million in Q2 FY2026, while transaction value rose to Rs 3,295 crore from Rs 3,049 crore. The opposite movement in volume and value indicates that the mix of activity changed across the company’s corporate, government, insurer and international channels during the quarter.

Government was the largest transaction-volume category, with 3.958 million transactions in Q2 FY2027, down from 4.058 million a year earlier. Government transaction value nevertheless rose to Rs 1,198 crore from Rs 1,145 crore. Corporate value increased to Rs 1,153 crore from Rs 1,095 crore, and international value rose to Rs 812 crore from Rs 667 crore.

Quarterly transaction volume was also below the 6.556 million reported in Q4 FY2026 and the 6.090 million in Q1 FY2027. However, Q2 FY2027 transaction value of Rs 3,295 crore was the highest among the five quarters presented, exceeding Rs 3,216 crore in Q1 FY2027 and Rs 3,205 crore in Q4 FY2026.

How large is Bajaj Health's network and TPA operation?

Bajaj Health reported a network of more than 32,000 hospitals, 130,000 doctors and 10,000 diagnostic touch points in Q2 FY2027. Its doctor network included more than 9,500 hospital doctors, and the diagnostic network included more than 4,300 centres across 400-plus cities and more than 5,600 home-collection pincodes. The company also reported more than 23,500 dental touch points.

For the 12 months from Q3 FY2026 to Q2 FY2027, corporate third-party administrator, or TPA, services had premium under management of Rs 3,879 crore and processed more than 1.1 million transactions. Ayushman Bharat TPA services had premium under management of Rs 722 crore, covered 121 million lives and processed more than 17.3 million transactions. Retail TPA services had premium under management above Rs 445 crore, four public-sector insurer relationships and more than 85,000 processed transactions.

Bajaj Health also reported more than 77 lakh active lives managed in its TPA business during H1 FY2027. It serviced more than 12.5 crore members in government schemes, processed 522,062 pre-authorisations and monitored 112,284 transactions for fraud prevention. The company said it prevented 4,634 fraud instances and saved Rs 44 crore during the half year.

Which healthcare businesses is Bajaj Health expanding?

Bajaj Health is organising operations into six business verticals: employer-employee, government services, retail products to insurers, value-add products, technology services and consumer services. Employer-employee services include TPA administration, structured outpatient department, or OPD, benefits, wellness and maternity services. Government services include claims processing and fraud-and-abuse services for central and state schemes.

The company reported more than 2,400 partners, nine state schemes and 28 TPA relationships with general or health insurers. It also listed 10 OPD products for general or health insurers, six OPD products for life insurers, 12 value-add-product partners, two international insurers and four Indian insurers. Its service canvas comprises 20 services spanning preventive through tertiary care.

OPD services covered 16 insurers, 414 corporates and 7 million lives in the 12 months from Q3 FY2026 to Q2 FY2027, processing 3.6 million transactions. International-insurer services had two partners, gross merchandise value of Rs 3,131 crore and more than 2.7 million transactions. During Q2 FY2027, Bajaj Health said it won the Tamil Nadu NHIS government employees and pensioners scheme and onboarded Star Health for OPD plans.

What do Bajaj Health's service metrics show about demand?

Bajaj Health recorded 19.63 million primary-care service instances in the 12 months from Q3 FY2026 to Q2 FY2027, making primary care its largest disclosed service category. Pharmacy represented 14.78 million instances, while general practitioner services and doctor consultations accounted for 3.28 million. These are service-instance measures rather than revenue disclosures by product or vertical.

Tertiary care accounted for 2.18 million service instances, including 853,708 advanced diagnostics and 748,468 multi-specialty care instances. Preventive services accounted for 2.12 million instances, led by 1.41 million preventive health check-ups and 398,087 step-tracker and vitals interactions. Secondary care recorded 544,041 instances, including 430,132 specialist consultations.

The service metrics align with Bajaj Health’s stated integrated model covering preventive, primary, secondary and tertiary care alongside cashless OPD and inpatient department, or IPD, journeys. The company also said more than 660 doctors supported claims adjudication and that 74.50% of discharges were completed within 60 minutes in H1 FY2027. The presentation does not provide service-level revenue, margins or acquisition costs.

How much capital has Bajaj Health received for expansion?

Bajaj Health had received cumulative capital infusion of Rs 1,250 crore as of 30 September 2026, including Rs 50 crore infused during FY2027. Net worth was Rs 414 crore on that date. These figures were reported alongside an H1 FY2027 loss after tax of Rs 102 crore.

The company’s technology plan includes an artificial intelligence-first claims-adjudication platform, platform-as-a-service and software-as-a-service offerings, and Enigma, described as a generative artificial intelligence-enabled claims-processing service. It also listed cashless booking, application programming interface integrations, ABHA-enabled health-vault services and e-hospital solutions among its digital capabilities. The presentation does not disclose a profitability date or financial target for these products.

Conclusion

Bajaj Health’s Q2 FY2027 data show lower reported income and a larger loss alongside an increase in transaction value. Total income fell to Rs 192 crore and loss after tax widened to Rs 58 crore, while healthcare transaction value reached Rs 3,295 crore despite volume declining to 5.694 million transactions. Corporate, government and international channels each posted higher transaction value than a year earlier.

The next disclosed developments to watch are the implementation of industry structural changes associated with the Reserve Bank of India circular and the Insurance Regulatory and Development Authority of India discussion paper, plus delivery from the Tamil Nadu NHIS award and Star Health OPD arrangement. Bajaj Health had Rs 1,250 crore of cumulative capital infusion and Rs 414 crore of net worth as of 30 September 2026, but disclosed no timetable for profitability.